Who We Are

The New Jersey Life Sciences Vendors Alliance (NJLSVA) is a coalition of businesses, individuals and academia who provide goods and services to New Jersey’s life sciences companies.

The NJLSVA was founded to educate suppliers on trends in industry procurement and public policy that affects the life sciences industry.

Drug Abuse

White House Opioid Commission Urges Trump: ‘Declare a National Emergency’ on Drug Overdoses; Chaired by Gov. Christie

Washington, DC, August 1, 2017 — Christopher Ingraham reports in The Washington Post that the President’s Commission on Combating Drug Addiction and the Opioid Crisis, chaired by Gov. Chris Christie, issued a preliminary report on Monday stating that its “first and most urgent recommendation” is for the president to “declare a national emergency under either the Public Health Service Act or the Stafford Act.”

“With approximately 142 Americans dying every day,” the report notes, “America is enduring a death toll equal to September 11th every three weeks.” Continue reading

Gov. Christie Signs Executive Order Declaring Opioid Drug Abuse a Public Health Crisis; Creates Drug Abuse Task Force

Governor Chris Christie

Governor Chris Christie

Trenton, NJ, January 18, 2017 — Intensifying his Administration’s commitment in the fight against substance abuse, Governor Chris Christie yesterday signed Executive Order 219 declaring the opioid epidemic a public health crisis in New Jersey.

The action requires the marshalling of all appropriate resources to combat its harmful effects on state citizens.

“We must take aggressive action to get this insidious crisis under control so I am calling together all resources of state government in order to save lives,” said Governor Christie. Continue reading

Christie Administration Announces CDC Grant Funding Totaling More than $7.6 Million to Combat Opioid Epidemic

Opioid Abuse 1Trenton, NJ, September 5, 2016New Jersey Business reports that Governor Chris Christie on September 1 announced that the Centers for Disease Control and Prevention (CDC) had awarded the New Jersey Department of Health (DOH) a $727,688 competitive grant to enhance efforts to curb the opioid crisis through a series of initiatives and the New Jersey Department of Human Services (DHS) approximately $6.9 million to target prescription and opioid misuse.

“Today is International Overdose Awareness Day, a reminder that the disease of addiction is preventable through education and intervention,” said Governor Christie.  “These funding grants are another important step in combating opioid misuse and abuse in New Jersey while strengthening our ability to positively impact the opioid crisis in our state by saving lives.” Continue reading

President Obama Signs Bill to Address Opioid Addition Despite Its Shortcomings

Opioid Abuse 2Washington, DC, July 25, 2016 The Hill reports that President Obama signed a bill aimed at addressing opioid addiction Friday, though he called out Republicans for the measure’s shortcomings.

Lawmakers in both parties reached a compromise over the bipartisan Comprehensive Addiction and Recovery Act, though Senate Democrats held out hope until the final hour that they could win more funding for treatment.

“This legislation includes some modest steps to address the opioid epidemic,” Obama said in a statement.  “Given the scope of this crisis, some action is better than none. However, I am deeply disappointed that Republicans failed to provide any real resources for those seeking addiction treatment to get the care that they need.” Continue reading

Congress Sends First Major Opioids Legislation to President Obama’s Desk

Opioid Abuse 2Washington, DC, July 14, 2016 — Dylan Scott reports on STAT that the first major legislation to address the growing crisis of opioid addiction is on its way to President Obama’s desk, after the Senate approved the package in a strong bipartisan vote on Wednesday.

In a show of the widespread agreement for action, 92 senators voted for the bill after it received more than 400 votes in the House last week.

The legislation, called the Comprehensive Addiction and Recovery Act, is a compilation of measures passed by the House and Senate in recent weeks to try to fight the epidemic of addiction to painkillers, which is now killing nearly 30,000 people annually in the United States. Continue reading

Governor Christie Announces Collaboration with New York in Fight Against Drug Addiction

Opioid Abuse 1Trenton, NJ, April 27, 2016 ― Governor Chris Christie announced yesterday that the States of New Jersey and New York have joined forces in the national fight against heroin and opioid addiction by sharing data to track prescription sales of narcotic painkillers and other drugs that often lead to addiction.

“New Jersey and New York share a close relationship in which our residents regularly travel between the states for business and pleasure,” Governor Christie said.  “Today we’re coming together for another purpose — to fight the devastating scourge of drug addiction.”

“By tracking the sale of prescription opioids across our state lines, doctors and prescribers in New Jersey and New York can work together to identify addicts seeking new places to feed their devastating habit,” the Governor said. Continue reading

Governor Christie Highlights One-Stop Resource for Substance Use Disorders

Chris Christie official portrait 2013

Governor Chris Christie

Trenton, NJ, April 25, 2016 ― Advancing his commitment to a smarter, more effective approach in how the State supports individuals with substance use disorders, Governor Chris Christie on Friday visited the Interim Management Entity (IME), a one-stop resource managed through Rutgers University Behavioral Health Care in Piscataway.

The IME, which has been operational since July 1, 2015, coordinates addiction treatment services with statewide providers to ensure accessible and appropriate care.

“Today, someone seeking assistance and looking for addiction resources no longer has to search endlessly for help,” said Governor Christie.  “With our IME call center, we’ve moved away from fragmented treatment options to a single point of entry for individuals in crisis and their families.” Continue reading

FDA Announces Enhanced Warnings for Immediate-Release Opioid Pain Medications

FDA blueWashington, DC, March 23, 2016 ― The U.S. Food and Drug Administration (FDA), in a continuing effort to educate prescribers and patients about the potential risks related to opioid use, yesterday announced required class-wide safety labeling changes for immediate-release (IR) opioid pain medications.

Among the changes, the FDA is requiring a new boxed warning about the serious risks of misuse, abuse, addiction, overdose and death.

Yesterday’s actions are among a number of steps the agency recently outlined in a plan to reassess its approach to opioid medications.  The plan is focused on policies aimed at reversing the epidemic, while still providing patients in pain access to effective relief. Continue reading

CDC Releases Guideline for Prescribing Opioids for Chronic Pain

Pills blue niceAtlanta, GA, March 16, 2016 ― As part of the U.S. government’s urgent response to the epidemic of overdose deaths, the Centers for Disease Control and Prevention (CDC) yesterday is issuing new recommendations for prescribing opioid medications for chronic pain, excluding cancer, palliative, and end-of-life care.

The CDC Guideline for Prescribing Opioids for Chronic Pain, United States, 2016 will help primary care providers ensure the safest and most effective treatment for their patients.

The United States is currently experiencing an epidemic of prescription opioid overdose. Increased prescribing and sales of opioids—a quadrupling since 1999— helped create and fuel this epidemic. Continue reading

STAT: Nancy Reagan: A ‘True Champion’ of Alzheimer’s, Stem-Cell Research, Breast Cancer Awareness

Nancy Reagan olderBoston, MA, March 7, 2016 ― Sheila Kaplan reports on STAT that former First Lady Nancy Reagan, who died yesterday at age 94, had a greater impact on public health than most Americans might recall.

Despite opposition from many Republican Party leaders, Reagan pushed for stem-cell research, established an Alzheimer’s research institute, and, like First Lady Betty Ford before her, talked publicly about her breast cancer treatment when the subject was still considered taboo in polite society.

“Hers was an important voice in the effort to advance medical science in the hope of improving people’s health,” said Dr. Francis Collins, director of the National Institutes of Health, in an email. Continue reading